| 1 |
Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections[J]. FEMS Microbiol Rev, 2008，32(6)：956-973.
|
| 2 |
Lee KY. Pediatric respiratory infections by Mycoplasma pneumoniae[J]. Expert Rev Anti Infect Ther, 2008，6(4)：509-521.
|
| 3 |
Spuesens E B, Fraaij P L, Visser E G, et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: An observational study[J]. PLoS Med, 2013，10(5)：e1001444.
|
| 4 |
Miyashita N, Kawai Y, Akaike H, et al. Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia[J]. BMC Infect Dis, 2012，12：126.
|
| 5 |
Xin D, Mi Z, Han X, et al. Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China[J]. Antimicrob Agents Chemother, 2009，53(5)：2158-2159.
|
| 6 |
Dumke R, von Baum H, Luck PC, et al. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany[J]. Clin Microbiol Infect, 2010，16(6)：613-616.
|
| 7 |
Peuchant O, Menard A, Renaudin H, et al. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis[J]. J Antimicrob Chemother, 2009，64(1)：52-58.
|
| 8 |
Oishi T, Narita M, Ohya H, et al. Rhabdomyolysis associated with antimicrobial drug-resistant Mycoplasma pneumoniae[J]. Emerg Infect Dis, 2012，18(5)：849-851.
|
| 9 |
Park IH, Choi DY, Oh YK, et al. A case of acute myopericarditis associated with Mycoplasma pneumoniae infection in a child[J]. Korean Circ J, 2012，42(10)：709-713.
|
| 10 |
Shimizu M, Hamaguchi Y, Matsushita T, et al. Sequentially appearing erythema nodosum, erythema multiforme and Henoch-Schonlein purpura in a patient with Mycoplasma pneumoniae infection: A case report[J]. J Med Case Rep, 2012，6(1)：398.
|
| 11 |
Berg CP, Kannan TR, Klein R, et al. Mycoplasma antigens as a possible trigger for the induction of antimitochondrial antibodies in primary biliary cirrhosis[J]. Liver Int, 2009，29(6)：797-809.
|
| 12 |
Cao B, Zhao CJ, Yin YD, et al. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China[J]. Clin Infect Dis, 2010，51(2)：189-194.
|
| 13 |
Matsubara K, Morozumi M, Okada T, et al. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients[J]. J Infect Chemother, 2009，15(6)：380-383.
|
| 14 |
Wang Y, Qiu S, Yang G, et al. An outbreak of Mycoplasma pneumoniae caused by a macrolide-resistant isolate in a nursery school in China[J]. Antimicrob Agents Chemother, 2012，56(7)：3748-3752.
|
| 15 |
Kannan T R, Hardy R D, Coalson J J, et al. Fatal outcomes in family transmission of Mycoplasma pneumoniae[J]. Clin Infect Dis, 2012，54(2)：225-231.
|
| 16 |
Morozumi M, Takahashi T, Ubukata K. Macrolide-resistant Mycoplasma pneumoniae: Characteristics of isolates and clinical aspects of community-acquired pneumonia[J]. J Infect Chemother, 2010，16(2)：78-86.
|
| 17 |
Morozumi M, Iwata S, Hasegawa K, et al. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia[J]. Antimicrob Agents Chemother, 2008，52(1)：348-350.
|
| 18 |
Liu Y, Ye X, Zhang H, et al. Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China[J]. Antimicrob Agents Chemother, 2009，53(5)：2160-2162.
|
| 19 |
Zhao F, Lv M, Tao X, et al. Antibiotic sensitivity of 40 Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant isolates from Beijing, China[J]. Antimicrob Agents Chemother, 2012，56(2)：1108-1109.
|
| 20 |
Isozumi R, Yoshimine H, Morozumi M, et al. Adult community-acquired pneumonia caused by macrolide resistant Mycoplasma pneumoniae[J]. Respirology, 2009，14(8)：1206-1208.
|
| 21 |
Waites KB, Balish MF, Atkinson TP. New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections[J]. Future Microbiol, 2008，3(6)：635-648.
|
| 22 |
Wolff BJ, Thacker WL, Schwartz SB, et al. Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis[J]. Antimicrob Agents Chemother, 2008，52(10)：3542-3549.
|
| 23 |
Liu XJ, Xin DL, Li J，et al.Molecular mechanisms of macrolides resistance in Mycoplasma pneumoniae[J]．J Appl Clin Pediatr, 2008，23(22)：1730-1733.
|
| 24 |
Pereyre S, Guyot C, Renaudin H, et al. In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae[J]. Antimicrob Agents Chemother, 2004，48(2)：460-465.
|
| 25 |
Ye Y, Li SL, Jiang P，et al.Analysis on Mycoplasma pneumoniae 23SrRNA gene mutation site and drug resistance phenotype[J]．Lab Med, 2013，28(1)：11-16.
|
| 26 |
Morozumi M, Hasegawa K, Kobayashi R, et al. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation[J]. Antimicrob Agents Chemother, 2005，49(6)：2302-2306.
|
| 27 |
Pan MA, Zhang TT, Zhu JX, et al.The study of drug resistance and mechanism of azithromycin for Mycoplasma pneumoniae[J]．Chin J Antibio，2010(09)：721-725.
|
| 28 |
Shi DW.Study on the induction of resistance to azithromycin in Mycoplasma pneumoniae[D]．BeiJing：Capital Medical Univerity, 2010：1-49.
|
| 29 |
Tagliabue C, Salvatore CM, Techasaensiri C, et al. The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection[J]. J Infect Dis, 2008，198(8)：1180-1188.
|
| 30 |
Lee KY, Lee HS, Hong JH, et al. Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children[J]. Pediatr Pulmonol, 2006，41(3)：263-268.
|
| 31 |
Tagliabue C, Techasaensiri C, Torres JP, et al. Efficacy of increasing dosages of clarithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia[J]. J Antimicrob Chemother, 2011，66(10)：2323-2329.
|
| 32 |
Averbuch D, Hidalgo-Grass C, Moses AE, et al. Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010[J]. Emerg Infect Dis, 2011，17(6)：1079-1082.
|
| 33 |
Meng Y, Huo J, Lu W, et al. Modulation of p1 and EGF expression by baicalin[J]. Int J Mol Sci, 2012，14(1)：146-157.
|
| 34 |
Ledford JG, Mukherjee S, Kislan MM, et al. Surfactant protein-A suppresses eosinophil-mediated killing of Mycoplasma pneumoniae in allergic lungs[J]. PLoS One, 2012，7(2)：e32436.
|
| 35 |
Gally F, Di YP, Smith SK, et al. SPLUNC1 promotes lung innate defense against Mycoplasma pneumoniae infection in mice[J]. Am J Pathol, 2011，178(5)：2159-2167.
|
| 36 |
Szczepanek SM, Majumder S, Sheppard ES, et al. Vaccination of BALB/c mice with an avirulent Mycoplasma pneumoniae P30 mutant results in disease exacerbation upon challenge with a virulent strain[J]. Infect Immun, 2012，80(3)：1007-1014.
|